Price to Sales ratio Analysis of Phathom Pharmaceuticals Inc - Deep Dive


Latest FY PS
Period Ending - Dec-23

853564


Very Poor PS
Period Ending - Dec-22
0

Very Poor PS
Growth
0 %
Trailing Twelve Months PS
Period Ending - Dec-23

171333


Very Poor PS
PS Analysis of Phathom Pharmaceuticals Inc
P/S Ratio of Phathom Pharmaceuticals Inc with value of 171333 indicates that stock price is high compared to sales of the company and may be overvalued.
PS Ratio of PHAT has grown by 0 % Compared to previous Financial Year.
PS Ratio with value of 853564 was highest in Year Dec-23 in last Five Years.
PS Ratio with value of 0 was lowest in Year Dec-22 in last Five Years.
Latest PS Ratio with value of 853564 is Greater than Average PS of 170712 in last five years.
Other PS Related Info of PHAT that may interest you.
Phathom Pharmaceuticals Inc Overview
CodePricePrevious PricePrice ChangeSector
PHAT11.3510.95 3.65 % Biotechnology
Fundamental AnalysisTechnical Analysis
Defination of Price to Sales
The Price to Sales Ratio indicates how much investors are willing to pay for each rupee of sales generated by a company. Price-to-Sales Ratio is used to determine whether a stock is currently profitable or less profitable, which is helpful for better investment decisions.   more ..
Price to Sales Formula

PS Related Ratios
PriceToBookRatioPriceToEarningRatioAssetTurnoverRatio

Tsr Value Index
Poor Value Stock
FY - Historical Price to Sales of Phathom Pharmaceuticals Inc
PeriodDec-23Dec-22Dec-21Dec-20Dec-19Dec-18
PS85356400000
Change
FY Chart of Price to Sales of Phathom Pharmaceuticals Inc


Note : All Data Generated at the End of Trading Hours (EOD Data)